I went to EXAS web-site. Very impressive!!!!! They have 14 employees:-) 5 are executives (they don't earn their keep) Uh--let me get my calculator---uh--that leaves 9 employees----oh, they secretary and assistant sec.--that leaves seven? Uh I'll double check---yup --it's seven----and a maintance man and a landscaper--that leaves five? Then there's the cafeteria worker and dishwasher--that leaves three. One lone person left. You think there's three left? WRONG!!! You and Stoob are on the payroll. BWAHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
What a dope you really are. EXAS will chew through that 25 million with BOD salaries,executive payouts and fu#k dopes like you until the stock hits zero. To sat that this stock has little risk because the price is near the cash per share is a stupid statement when you are only talking about 20+ million. This Pos could easily drift back to 40 cents and by my math that would be a loss of apprx. 55%.
Don't forget the guy running the printing press, cranking out fresh dilutive shares daily to send off to GENZ. That is a full-time job. -------------- "Exact Sciences said in a brief statement it was pursuing a "strategic alternative" that its board believes will offer greater value to shareholders than the Sequenom deal. The statement did not elaborate." -------------- LOL! Yes, massive dilution and the divestment of core pipeline technology has been great for shareholders. I guess the "elaboration" that was missing was EXAS mgt's belief that the money generated for bonuses and salaries to keep them employed would be a boon for shareholders, based on their splendid track record of generating returns on shareholder investments.
We sold 10% of the company, and rights to technology totally outside of our core area (CRC cancer screening) for about $24 million plus other benefits. On what planet is that not a much, much better deal than selling the whole company for $41 million in SQNM stock (which, by now, would be worth quite a lot less)?